Literature DB >> 22214600

The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury.

Alison J Kriegel1, Yong Liu, Yi Fang, Xiaoqiang Ding, Mingyu Liang.   

Abstract

The human miR-29 family of microRNAs has three mature members, miR-29a, miR-29b, and miR-29c. miR-29s are encoded by two gene clusters. Binding sites for several transcriptional factors have been identified in the promoter regions of miR-29 genes. The miR-29 family members share a common seed region sequence and are predicted to target largely overlapping sets of genes. However, the miR-29 family members exhibit differential regulation in several cases and different subcellular distribution, suggesting their functional relevance may not be identical. miR-29s directly target at least 16 extracellular matrix genes, providing a dramatic example of a single microRNA targeting a large group of functionally related genes. Strong antifibrotic effects of miR-29s have been demonstrated in heart, kidney, and other organs. miR-29s have also been shown to be proapoptotic and involved in the regulation of cell differentiation. It remains to be explored how various cellular effects of miR-29s determine functional relevance of miR-29s to specific diseases and how the miR-29 family members may function cooperatively or separately.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22214600      PMCID: PMC3289120          DOI: 10.1152/physiolgenomics.00141.2011

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  104 in total

Review 1.  MicroRNA: a new entrance to the broad paradigm of systems molecular medicine.

Authors:  Mingyu Liang
Journal:  Physiol Genomics       Date:  2009-05-26       Impact factor: 3.107

2.  Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation.

Authors:  Zhaoyong Li; Mohammad Q Hassan; Mohammed Jafferji; Rami I Aqeilan; Ramiro Garzon; Carlo M Croce; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  J Biol Chem       Date:  2009-04-02       Impact factor: 5.157

Review 3.  MicroRNA: a new frontier in kidney and blood pressure research.

Authors:  Mingyu Liang; Yong Liu; Domagoj Mladinov; Allen W Cowley; Hariprasad Trivedi; Yi Fang; Xialian Xu; Xiaoqiang Ding; Zhongmin Tian
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-01

Review 4.  Transforming growth factor beta in tissue fibrosis.

Authors:  W A Border; N A Noble
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

5.  Fibrinogen and risk of cardiovascular disease. The Framingham Study.

Authors:  W B Kannel; P A Wolf; W P Castelli; R B D'Agostino
Journal:  JAMA       Date:  1987-09-04       Impact factor: 56.272

6.  Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy.

Authors:  S C Tyagi; S G Kumar; S J Haas; H K Reddy; D J Voelker; M R Hayden; T L Demmy; R A Schmaltz; J J Curtis
Journal:  J Mol Cell Cardiol       Date:  1996-07       Impact factor: 5.000

Review 7.  Modes of p53 regulation.

Authors:  Jan-Philipp Kruse; Wei Gu
Journal:  Cell       Date:  2009-05-15       Impact factor: 41.582

8.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

Authors:  R C Lee; R L Feinbaum; V Ambros
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

9.  MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors.

Authors:  Hong Xu; Irene Y Cheung; Hong-Fen Guo; Nai-Kong V Cheung
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

Review 10.  MicroRNAs and their role in progressive kidney diseases.

Authors:  Mitsuo Kato; Laura Arce; Rama Natarajan
Journal:  Clin J Am Soc Nephrol       Date:  2009-07       Impact factor: 8.237

View more
  215 in total

Review 1.  Translational study of microRNAs and its application in kidney disease and hypertension research.

Authors:  Alison J Kriegel; Domagoj Mladinov; Mingyu Liang
Journal:  Clin Sci (Lond)       Date:  2012-05-01       Impact factor: 6.124

Review 2.  Role of microRNAs in the trabecular meshwork.

Authors:  Pedro Gonzalez; Guorng Li; Jianming Qiu; Jing Wu; Coralia Luna
Journal:  J Ocul Pharmacol Ther       Date:  2014-01-02       Impact factor: 2.671

3.  Evaluation of miR-29c inhibits endotheliocyte migration and angiogenesis of human endothelial cells by suppressing the insulin like growth factor 1.

Authors:  Yun Hu; Feng Deng; Jinlin Song; Juhong Lin; Xue Li; Yuying Tang; Jie Zhou; Tian Tang; Leilei Zheng
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

4.  Special suppressive role of miR-29b in HER2-positive breast cancer cells by targeting Stat3.

Authors:  Ling Qin; Rong Li; Junyi Zhang; Aimin Li; Rongcheng Luo
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

5.  Evaluation of miR-29c inhibits endotheliocyte migration and angiogenesis of human endothelial cells by suppressing the insulin like growth factor 1.

Authors:  Yun Hu; Feng Deng; Jinlin Song; Juhong Lin; Xue Li; Yuying Tang; Jie Zhou; Tian Tang; Leilei Zheng
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

6.  MicroRNA-29b-3p Targets SPARC Gene to Protect Cardiocytes against Autophagy and Apoptosis in Hypoxic-Induced H9c2 Cells.

Authors:  Shu Zhou; Dazhou Lei; Faqin Bu; Hongqiang Han; Shucai Zhao; Yan Wang
Journal:  J Cardiovasc Transl Res       Date:  2018-12-17       Impact factor: 4.132

Review 7.  Role of the microRNA-29 family in myocardial fibrosis.

Authors:  Changyan Li; Nan Wang; Peng Rao; Limeiting Wang; Di Lu; Lin Sun
Journal:  J Physiol Biochem       Date:  2021-05-28       Impact factor: 4.158

Review 8.  Targeting the progression of chronic kidney disease.

Authors:  Marta Ruiz-Ortega; Sandra Rayego-Mateos; Santiago Lamas; Alberto Ortiz; Raul R Rodrigues-Diez
Journal:  Nat Rev Nephrol       Date:  2020-02-14       Impact factor: 28.314

9.  Pregnancy-driven cardiovascular maternal miR-29 plasticity in obesity.

Authors:  N Schlabritz-Loutsevitch; K Apostolakis-Kyrus; R Krutilina; G Hubbard; M Kocak; Z Janjetovic; S Sathanandam; A T Slominski; G Mari; E Dick
Journal:  J Med Primatol       Date:  2016-09-15       Impact factor: 0.667

10.  Therapeutic Potential of OMe-PS-miR-29b1 for Treating Liver Fibrosis.

Authors:  Virender Kumar; Vinod Kumar; Jiangtao Luo; Ram I Mahato
Journal:  Mol Ther       Date:  2018-09-01       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.